13F HOLDINGS REPORT
Caligan Partners LP
Quarter ended Q2 2024 · Filed August 14, 2024 · Accession 0001814554-24-000010
Total Value
$428.0M
Positions
13
Other Managers
0
Confidential Omitted
No
Holdings (13)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | LIQUIDIA CORPORATION | LQDA | 10,360,945 | $124.3M | 29.05% |
| 2 | ALIMERA SCIENCES INC | 016259202 | 16,835,154 | $93.6M | 21.87% |
| 3 | ANIKA THERAPEUTICS INC | ANIK | 1,435,993 | $36.4M | 8.50% |
| 4 | EXELIXIS INC | EXEL | 1,525,730 | $34.3M | 8.01% |
| 5 | BIOCRYST PHARMACEUTICALS INC | BCRX | 4,598,737 | $28.4M | 6.64% |
| 6 | VERONA PHARMA PLC | 925050106 | 1,843,756 | $26.7M | 6.23% |
| 7 | EVOLUS INC | EOLS | 2,167,790 | $23.5M | 5.50% |
| 8 | AGIOS PHARMACEUTICALS INC | AGIO | 514,711 | $22.2M | 5.19% |
| 9 | ENANTA PHARMACEUTICALS INC | ENTA | 1,042,889 | $13.5M | 3.16% |
| 10 | MINERALYS THERAPEUTICS INC | MLYS | 745,758 | $8.7M | 2.04% |
| 11 | Y-MABS THERAPEUTICS INC | 984241109 | 582,078 | $7.0M | 1.64% |
| 12 | I MAB | NBP | 3,374,791 | $5.6M | 1.32% |
| 13 | OUTLOOK THERAPEUTICS INC | OTLK | 500,000 | $3.7M | 0.86% |